Athos Capital’s NxStage Medical Inc. NXTM Stock Holding History

Athos Capital’s Portfolio NXTM Stock Details NXTM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-110,784	Closed	-$3.17M	–	29
2018 Q4	$3.17M	Buy	110,784 +17,741	+19%	+$504K	3.14%	8
2018 Q3	$2.6M	Buy	93,043 +63,043	+210%	+$1.77M	1.38%	15
2018 Q2	$837K	Sell	30,000 -42,777	-59%	-$1.15M	0.28%	26
2018 Q1	$1.81M	Sell	72,777 -1,400	-2%	-$34.1K	0.74%	15
2017 Q4	$1.8M	Buy	74,177 +53,207	+254%	+$1.4M	1.74%	16
2017 Q3	$579K	Buy	+20,970	New	+$559K	0.44%	27

Other funds holding NXTM

TAL

TIG Advisors LLC New York $2.16B AUM 72.99% 1-Year Est. Return

Athos Capital's NXTM Position: Q1 2019 in Review

Athos Capital sold out of NxStage Medical Inc. (NXTM) in Q1 2019, closing a stake of 110,784 shares — an estimated $3.17M sold.

Athos Capital first reported a position in NXTM in Q3 2017 and held it in 6 quarters. The position peaked at $3.17M in Q4 2018. 1 fund tracked by Wall St. Rank holds NXTM as of Q1 2019.

Athos Capital reported no remaining NxStage Medical Inc. position as of Q1 2019 after selling out during the quarter.
Athos Capital sold 110,784 NxStage Medical Inc. shares in Q1 2019, an estimated $3.17M.
Athos Capital first reported a position in NxStage Medical Inc. in Q3 2017 and held it in 6 quarters.
Athos Capital's NxStage Medical Inc. position peaked at $3.17M in Q4 2018.
1 fund tracked by Wall St. Rank held NxStage Medical Inc. as of Q1 2019.

Based on Athos Capital's 13F filing for Q1 2019, filed 14 May 2019.